UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fabry disease peripheral blood immune cells release inflammatory cytokines: Role of globotriaosylceramide

Molecular genetics and metabolism, 2013-05, Vol.109 (1), p.93-99

2013

Volltextzugriff (PDF)

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease

PloS one, 2019-05, Vol.14 (5), p.e0217780-e0217780

2019

Volltextzugriff (PDF)

Fabry pedigree analysis: A successful program for targeted genetic approach

Molecular genetics & genomic medicine, 2019-07, Vol.7 (7), p.e00794-n/a

2019

Volltextzugriff (PDF)

MPS II models for the study of joint and bone pathophysiology using CRISPR/Cas9 technology

Molecular genetics and metabolism, 2024-02, Vol.141 (2), p.108060, Article 108060

2024

Volltextzugriff (PDF)

Higher apoptotic state in Fabry disease peripheral blood mononuclear cells

Molecular genetics and metabolism, 2011-11, Vol.104 (3), p.319-324

2011

Volltextzugriff (PDF)

An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: Utility for Fabry disease diagnosis and treatment monitoring

Clinica chimica acta, 2009-05, Vol.403 (1), p.194-197

2009

Volltextzugriff (PDF)

Lyso-Gb3 determination in classic and late onset Fabry patients

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107299, Article 107299

2023

Volltextzugriff (PDF)

Generation of an model for Hunter syndrome using CRISPR/Cas9 technology

Molecular genetics and metabolism, 2023-02, Vol.138 (2), p.107339, Article 107339

2023

Volltextzugriff (PDF)

Generation of an in vitro model for Hunter syndrome using CRISPR/Cas9 technology

Molecular genetics and metabolism, 2023-02, Vol.138 (2)

2023

Volltextzugriff (PDF)

Control de calidad en el diagnóstico serológico del virus de la inmunodeficiencia humana

Acta bioquímica clínica latinoamericana, 2009, Vol.43 (1)

2009

Volltextzugriff (PDF)

Osteocytes contribute to bone pathology in Gaucher disease

Molecular genetics and metabolism, 2017-01, Vol.120 (1-2), p.S28-S29

2017

Volltextzugriff (PDF)

Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α

Gene, 2012-11, Vol.509 (1), p.51-59

2012

Volltextzugriff (PDF)

Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results (I2.012)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results (P3.229)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Higher apoptotic state in Fabry disease peripheral blood mononuclear cells.: effect of globotriaosylceramide

Molecular genetics and metabolism, 2011-11, Vol.104 (3), p.319-324

2011

Volltextzugriff (PDF)

Evaluación de la función renal para la detección y seguimiento de la enfermedad renal crónica. Documento multidisciplinario de consenso 2021. Especial atención sobre situaciones clínicas específicas

Bioquímica y patología clínica, 2021-12, Vol.86 (1), p.56-81

2021

Volltextzugriff (PDF)

Uncoupling of osteoblast–osteoclast regulation in a chemical murine model of Gaucher disease

Gene, 2013-12, Vol.532 (2), p.186-191

2013

Volltextzugriff (PDF)

Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfa

Medicina, 2021, Vol.81 (2), p.173

2021

Volltextzugriff (PDF)

Evaluación de la función renal para la detección y seguimiento de la Enfermedad Renal Crónica. Documento Multidisciplinario de Consenso 2021. Especial atención sobre situaciones clínicas específicas (Resumen ejecutivo)

Revista de nefrología, diálisis y transplante, 2021, Vol.41 (4), p.300-303

2021

Volltextzugriff (PDF)

Globotriaosylceramide (Gb3) induces a proinflammatory cytokine profile in dendritic cells and macrophages: Consequences for Fabry disease

Molecular genetics and metabolism, 2013-02, Vol.108 (2), p.S33-S33

2013

Volltextzugriff (PDF)

The Continuous Challenge of Diagnosing patients with Fabry disease in Argentina: Genotype, Experiences, Anecdotes, and New Learnings

Journal of inborn errors of metabolism and screening, 2015-12, Vol.3, p.232640981561380

2015

Volltextzugriff (PDF)

Serum creatinine. From clinical practice to epidemiology through determination standards and quality control across clinical laboratories

Revista de nefrología, diálisis y transplante, 2016-09, Vol.36 (3), p.187-196

2016

Volltextzugriff (PDF)

The Continuous Challenge of Diagnosing patients with Fabry disease in Argentina

Journal of inborn errors of metabolism and screening, 2015-10, Vol.3

2015

Volltextzugriff (PDF)

La creatinina sérica. Desde la clínica a la epidemiología, a través de la estandarización de su determinación y el control de los laboratorios clínicos

Revista de nefrología, diálisis y transplante, 2016, Vol.36 (3), p.187-196

2016

Volltextzugriff (PDF)

Guidelines for diagnosis, monitoring and treatment of Fabry disease

Medicina (Buenos Aires), 2013, Vol.73 (5), p.482-494

2013

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Fabry disease peripheral blood immune cells release inflammatory cytokines: Role of globotriaosylceramide

Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease

Fabry pedigree analysis: A successful program for targeted genetic approach

MPS II models for the study of joint and bone pathophysiology using CRISPR/Cas9 technology

Higher apoptotic state in Fabry disease peripheral blood mononuclear cells

An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: Utility for Fabry disease diagnosis and treatment monitoring

Lyso-Gb3 determination in classic and late onset Fabry patients

Generation of an model for Hunter syndrome using CRISPR/Cas9 technology

Generation of an in vitro model for Hunter syndrome using CRISPR/Cas9 technology

Control de calidad en el diagnóstico serológico del virus de la inmunodeficiencia humana

Osteocytes contribute to bone pathology in Gaucher disease

Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α

Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results (I2.012)

Argentinean Initiative of Stroke in the Young and Fabry Disease (FD): Final Results (P3.229)

Higher apoptotic state in Fabry disease peripheral blood mononuclear cells.: effect of globotriaosylceramide

Evaluación de la función renal para la detección y seguimiento de la enfermedad renal crónica. Documento multidisciplinario de consenso 2021. Especial atención sobre situaciones clínicas específicas

Uncoupling of osteoblast–osteoclast regulation in a chemical murine model of Gaucher disease

Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfa

Evaluación de la función renal para la detección y seguimiento de la Enfermedad Renal Crónica. Documento Multidisciplinario de Consenso 2021. Especial atención sobre situaciones clínicas específicas (Resumen ejecutivo)

Globotriaosylceramide (Gb3) induces a proinflammatory cytokine profile in dendritic cells and macrophages: Consequences for Fabry disease

The Continuous Challenge of Diagnosing patients with Fabry disease in Argentina: Genotype, Experiences, Anecdotes, and New Learnings

Serum creatinine. From clinical practice to epidemiology through determination standards and quality control across clinical laboratories

The Continuous Challenge of Diagnosing patients with Fabry disease in Argentina

La creatinina sérica. Desde la clínica a la epidemiología, a través de la estandarización de su determinación y el control de los laboratorios clínicos

Guidelines for diagnosis, monitoring and treatment of Fabry disease

Suchergebnisse filtern